The relationship between signaling through the MAPK pathway and drug sensitivity is further supported by a previous report showing that sensitivity to the apoptotic agent fenretinide is dependent on activation of p38 and JNK MAPKs in Ewing sarcoma cells (27). This evidence concerns the gene MAPK8 and Ewing sarcoma.